These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6229106)

  • 1. [Clinical, microbiological and cytological changes in the gingiva as affected by Deposiston].
    Ludwig C; Arnold M; Ludwig A
    Zahn Mund Kieferheilkd Zentralbl; 1983; 71(6):587-94. PubMed ID: 6229106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bloodless determination of the partial pressure of oxygen in the gingiva as a longitudinal study conducted in the case of administration of hormonal contraceptives (author's transl)].
    Arnold M
    Zahn Mund Kieferheilkd Zentralbl; 1981; 69(2):97-104. PubMed ID: 6168138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of the gingival cytogram for the evaluation of hormonal contraceptives].
    Klinger G; Sommer K; Klinger G
    Stomatol DDR; 1979 Jan; 29(1):11-5. PubMed ID: 373163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 5. Vitreous haemorrhage in a 19-year-old Japanese woman using an oral contraceptive.
    Higa A; Ayaki M; Nishihara H; Inoue T; Ishida Y; Yaguchi S; Tsuda G; Saotome T
    Acta Ophthalmol Scand; 2004 Apr; 82(2):244-6. PubMed ID: 15043555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risk-benefit evaluation of the "micropill" is positive. Results of a multicenter study with Trinovum].
    Feldmann HU
    Gynakol Rundsch; 1986; 26 Suppl 1():43-56. PubMed ID: 3539717
    [No Abstract]   [Full Text] [Related]  

  • 7. First chewable oral contraceptive.
    FDA Consum; 2004; 38(2):4. PubMed ID: 15101351
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptive use and risk of stroke.
    Xuereb M; Pullicino P
    Stroke; 1988 Jul; 19(7):922-3. PubMed ID: 3388464
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of Deposiston on hormone secretion of the renin-aldosterone system, the adrenal cortex and the pituitary - ovary system].
    Branczeisz J; Hubl W; Freymann E; Sarembe B
    Z Arztl Fortbild (Jena); 1983; 77(3):109-11. PubMed ID: 6344451
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormonal contraceptives in female rowers].
    Lisý Z
    Cas Lek Cesk; 1984 Aug; 123(35):1086-90. PubMed ID: 6498900
    [No Abstract]   [Full Text] [Related]  

  • 11. Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
    Shoupe D
    Obstet Gynecol; 1994 May; 83(5 Pt 1):679-85. PubMed ID: 8164925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early symptoms and discontinuation among users of oral contraceptives in Sri Lanka.
    Basnayake S; Higgins JE; Miller PC; Rogers SM; Kelly SE
    Stud Fam Plann; 1984; 15(6 Pt 1):285-90. PubMed ID: 6393460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestin, thrombophlebitis and migraine.
    Ask-Upmark E
    Acta Med Scand; 1967 Jan; 181(6):737-8. PubMed ID: 4951472
    [No Abstract]   [Full Text] [Related]  

  • 14. By the way, doctor. I have recently lost a cousin in her mid-forties to melanoma. She was fair-skinned and had a family history of melanoma and other cancers. Doctors suggested there might be a connection between her oral contraceptive, Loestrin, and the melanoma. Could this be true?
    Nicholson CR
    Harv Womens Health Watch; 1999 Sep; 7(1):8. PubMed ID: 10445996
    [No Abstract]   [Full Text] [Related]  

  • 15. Sudden deafness and the contraceptive pill.
    Hanna GS
    J Laryngol Otol; 1986 Jun; 100(6):701-6. PubMed ID: 3723005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of sexual hormone anticoncipiens on periodontal tissue].
    Tu N; Li Z; You S
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Nov; 30(6):349-51. PubMed ID: 8762540
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
    Molina RC; Sandoval JZ; Montero AV; Oyarzún PG; Molina TG; González EA
    J Pediatr Adolesc Gynecol; 2009 Feb; 22(1):25-31. PubMed ID: 19232299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of synthetic sexual steroids on blood volume (author's transl)].
    Klinger G; Stoll W; Zinner G; Krause G; Carol W
    Zentralbl Gynakol; 1982; 104(6):343-8. PubMed ID: 7046293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives do not affect magnesium in breast milk.
    Dórea JG
    Int J Gynaecol Obstet; 2000 Oct; 71(1):25-31. PubMed ID: 11044538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol).
    Andolsek KM; Burkman RT; Kafrissen ME; Olson W; Osterman J
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():122-5. PubMed ID: 8260970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.